Eldorado Gold Corp (EGO) 3.05 $EGO Eldorado Gold reports

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Eldorado Gold Corp (EGO) 3.05 $EGO

Eldorado Gold reports 4Q loss
Automated Insights - Wed Mar 23, 5:25PM CDT
VANCOUVER, British Columbia (AP) _ Eldorado Gold Corp. (EGO) on Wednesday reported a fourth-quarter loss of $1.24 billion, after reporting a profit in the same period a year earlier.
EGO: 3.05 (-0.09), ELD.TO: 4.04 (-0.14)

Eldorado Reports 2015 Year-End and Fourth Quarter Financial and Operational Results
PR Newswire - Wed Mar 23, 5:04PM CDT
2015: Another Solid Year of Production
EGO: 3.05 (-0.09), ELD.TO: 4.04 (-0.14)

Eldorado Gold (EGO) Stock is Sinking as Gold Prices Slump
at The Street - Wed Mar 23, 3:15PM CDT
Eldorado Gold (EGO)
EGO: 3.05 (-0.09)

Eldorado Gold (EGO) Stock Slips Ahead of Upcoming Quarterly Results
at The Street - Tue Mar 22, 1:28PM CDT
Eldorado Gold (EGO) shares are falling on Tuesday afternoon ahead of the company's fourth quarter 2015 financial results set to be released on Wednesday after the closing bell.
EGO: 3.05 (-0.09)

Eldorado Gold (EGO) Stock Declines on Falling Gold Prices
at The Street - Fri Mar 18, 9:58AM CDT
Eldorado Gold (EGO) stock is retreating in mid-morning trading as gold prices drop on a stronger dollar.
EGO: 3.05 (-0.09)

Eldorado Gold: Will it Shine or Stay Dull?
at The Street - Thu Mar 10, 2:48PM CST
Pay attention to EGO's movement and look at what the signs are pointing to. 
EGO: 3.05 (-0.09)

Eldorado Gold (EGO) Stock Jumps as Gold Prices Increase
at The Street - Fri Mar 04, 2:18PM CST
Eldorado Gold (EGO) stock is gaining on Friday afternoon as higher gold prices lift some gold mining stocks.
EGO: 3.05 (-0.09)

Eldorado Gold (EGO) Stock Soaring as Gold Prices Rise
at The Street - Thu Mar 03, 2:17PM CST
Eldorado Gold (EGO) stock is up as gold prices trade in the green today.
EGO: 3.05 (-0.09)

Abitibi Royalties "Royalty Search" & Financial Update: Additional 1% NSR Purchased on the Menderes Project Surrounding Eldorado Gold's Efemcukuru Mine
Marketwired - Fri Feb 05, 7:01AM CST
Abitibi Royalties Inc. (TSX VENTURE: RZZ) ("Abitibi Royalties" or the "Company" is pleased to announce that it has entered into a binding Letter of Intent with Frontline Gold Corp. ("Frontline" to acquire an additional 1% net smelter royalty ("NSR" on its Menderes Gold Project, increasing the Company's NSR interest to 2%. The Menderes Gold Project surrounds Eldorado Gold Corporation's Efemcukuru gold mine in Turkey on three sides (Fig. 1). This is the eleventh royalty purchased near an existing mine since the "Royalty Search" was launched on June 9th.
EGO: 3.05 (-0.09), RZZ.VN: 3.650 (-0.140)

Why Gold Stocks Looked (Mostly) Lustrous on Thursday
Sean Williams, The Motley Fool - Motley Fool - Thu Feb 04, 9:48PM CST
Image source: Pixabay. Gold stocks are (mostly) on fire. During Thursday's trading session, we witnessed the following intraday gains: El Dorado Gold : up 14% Kinross Gold : up 18% New Gold : up 10% Harmony Gold Mining : up 12% ...
HMY: 3.74 (+0.05), EGO: 3.05 (-0.09), KGC: 3.02 (+0.08), NGD: 3.55 (+0.09), RGLD: 50.19 (+1.01), PPP: 1.75 (-0.04)

Eldorado Gold (EGO) Stock Surges on Rallying Gold Prices
at The Street - Thu Feb 04, 2:56PM CST
Eldorado Gold (EGO) stock is rising in late afternoon trading as gold prices gain.
EGO: 3.05 (-0.09)

Decision Time at Barrick Gold Corp. As It Prepares for $3 Billion in Writedowns
Rich Duprey, The Motley Fool - Motley Fool - Wed Feb 03, 11:15AM CST
Barrick Gold's open pit mine at Pascua Lama remains a festering wound on its financial statements. Image source: Barrick Gold. Even though gold has seen a modest price jump recently, the precious metal has been in a slump for so long that  Barrick...
EGO: 3.05 (-0.09), ABX: 13.56 (+0.29), GG: 15.78 (+0.37)

Integra Gold Corp. Signs Share Purchase Agreement With Eldorado Gold Corporation for $2,446,850
Marketwired - Tue Feb 02, 8:04AM CST
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN
ICG.VN: 0.445 (+0.015), EGO: 3.05 (-0.09), ELD.TO: 4.04 (-0.14)

Analyst Insight on Equities in Limelight - Comprehensive Research on Atmel, Eldorado Gold, Select Medical Holdings and Och-Ziff Capital Management
ACCESSWIRE - Wed Jan 27, 7:16AM CST
NEW YORK, NY / ACCESSWIRE / January 27, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Atmel Corp. (NASDAQ: ATML), Eldorado Gold Corp. (NYSE: EGO), Select Medical Holdings Corp. (NYSE: SEM) and Och-Ziff Capital Management Group LLC (NYSE: OZM). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
ATML: 8.09 (-0.02), EGO: 3.05 (-0.09), OZM: 4.00 (-0.01), SEM: 11.13 (-0.20)

Eldorado Gold (EGO) Stock Tanks, Expects Up to $1.6 Billion Charge
at The Street - Mon Jan 25, 1:21PM CST
Eldorado Gold (EGO) stock is plunging after warning that it expects an impairment charge of as much as $1.6 billion.
EGO: 3.05 (-0.09)

Why Eldorado Gold Corp. Shares Slumped
Brian D. Pacampara, CFA, The Motley Fool - Motley Fool - Mon Jan 25, 11:47AM CST
What: Shares of gold explorer Eldorado Gold were off 12.3% at 10:45 a.m. ET on Monday after its preliminary 2015 results and guidance disappointed Wall Street. So what: Eldorado shares have slumped sharply over the past year on concerns...
EGO: 3.05 (-0.09)

Eldorado Announces Preliminary 2015 Operational Results and 2016 Guidance
PR Newswire - Mon Jan 25, 6:00AM CST
TSX: ELD NYSE: EGO
EGO: 3.05 (-0.09), ELD.TO: 4.04 (-0.14)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 233

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 155

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 351

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 122

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
IEHP's Wellness Center Launch Faces Delay in California

Updated Category News Views 115

Unexpected Delay for IEHP's Community Hub Straight outta Rancho Cucamonga, we've got some news that'll have folks in San Bernardino holding their breath a little longer. The Inland Empire Health Plan (or IEHP if you're part of the 1.4 million served by them) had folks pumped for their new Community Wellness Center. But guess what? They had to slam the brakes on the grand...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Beko Pushes for Policy Synergy Amidst Carbon Shakeup

Updated Category News Views 166

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 166

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 116

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 244

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading

Top 5 Most Recently Viewed Articles

R Systems Shines as a Major Contender in Engineering Services

Updated Category News Views 206

R Systems Acknowledged for Engineering Excellence R Systems International Limited, a leader in digital product engineering and technology solutions, has been recognized in the latest evaluation conducted by Everest Group. This prominent acknowledgment positions R Systems as a Major Contender in the ISV and Internet-specific SPES PEAK Matrix® Assessment for the year 2024....

Continue Reading
AppFolio Achieves Growth: Analysts Reaffirm $300 Target

Updated Category News Views 68

DA Davidson Affirms $300 Price Target for AppFolio Recently, DA Davidson reaffirmed its Buy rating for AppFolio (NASDAQ: APPF) and maintained a price target of $300. As a leading provider of cloud-based software solutions, AppFolio is recognized for its strategic growth initiatives. The firm highlighted the company's momentum ahead of its third-quarter earnings report and...

Continue Reading
Important Class Action Emerging for West Pharmaceutical Services Investors

Updated Category News Views 162

Class Action Overview for West Pharmaceutical Services, Inc. Levi & Korsinsky, LLP informs all investors in West Pharmaceutical Services, Inc. about a significant class action securities lawsuit arising from claims of securities fraud against the company. This announcement serves as an important notice to those who hold shares of West Pharmaceutical Services, Inc. (NYSE:...

Continue Reading
Zelluna's Upcoming Forum: Insight into Cancer Treatment Strategies

Updated Category News Views 190

Explore the Upcoming Investor Forum by Zelluna Zelluna (OSE: ZLNA), a trailblazer in the realm of allogeneic 'off the shelf' T Cell Receptor-based Natural Killer (TCR-NK) cells aimed at combating cancer, has announced an engaging Investor Science and Strategy Forum that offers a closer look at their innovative approaches. This notable event is set to take place in Oslo,...

Continue Reading
Challenges Facing Airlines Due to Economic Shifts and Strikes

Updated Category News Views 296

Understanding the Shift in Airline Operations As airlines adapt to changing economic conditions and demand patterns, many have begun scaling back their flight offerings to certain international markets. The situation is particularly pronounced with regards to flights to China, where reduced demand and rising operational costs have forced several airlines to reconsider...

Continue Reading